Search

everythinglearnresearchcommunity

for

Search:↓

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Hair-Thread Tourniquet Syndrome is a rare condition where hair or thread tightly wraps around a child's body part, requiring quick treatment to prevent damage.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Oxytocin may help hair grow by increasing hair growth-related genes and factors.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Most mothers who get postpartum care are healthy during the postpartum period.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Women with thinning hair have thinner hair strands than women without hair loss.

Pregnant women's hair gets thicker.

Oral contraceptives may cause hair loss in women.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Monkeys with hair loss during pregnancy showed higher stress hormone levels and invested differently in their offspring.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

First-time mothers had higher stress hormone levels in late pregnancy than mothers who had given birth before.